Skip to end of metadata
Go to start of metadata

You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 8 Next »

Date

Discourse SEC calls

Participants

Goals

  • previous meeting:

Discussion topics

Item

Presenter

Notes

5 min

Opening

USEFUL Jira RESOURCE: CRs I have not accepted.

15 min

PR / CR processing

Thomas Beale , Joost Holslag

Progress:

10 min

Archie 2.0 announce

Pieter Bos

5 min

TDS / TDD - progress report

Heath Frankel (Unlicensed) (+Erik Sundvall)

Any progress over last 2 weeks.

15 min

EHR Index service (see also IHE services PIX / PDQ)

Heath Frankel (Unlicensed) Seref Arikan (Personal)

Discuss defining this service?

See placeholder in Platform Service Model.

25 mins

GUI hints / rules etc

Erik Sundvall

See Discourse thread.

15 min

Conformance framework - progress; call for participation

Thomas Beale Pablo Pazos

Seref Arikan (Personal) - need to find out current regression / passing situation - probably not 100%

10 min

SEC governance:

  • ToR doc - propose vote (needs 2/3 majority)

  • resignations

  • co-chair elections

Thomas Beale Sebastian Iancu

10 mins

Endpoint for committing persistent composition

Matija Polajnar

EDIT: there is now a wiki page for this topic and a Discourse discussion.

Need an atomic operation of committing a certain COMP iff doesn’t already exist (e.g. no meds list yet), i.e. can’t create accidental duplicates; problem of race condition of N clients trying to create a Meds list; could be done by checking a business rule settable in a given deployment that limits some template xyz to only one instance. Where are the rule(s) encoded? Heath Frankel (Unlicensed) What about when the Composition is part of a multi-Composition Contribution?

Potentially this needs to be managed in the back-end site-level config / rules.

Seref Arikan (Personal) one approach for dedicated API for Meds list. FHIR…

Erik Sundvall endpoint ‘black list’ - special template ids? Should be a customer question

Next SEC call

Outstanding topics:

Outstanding topics:

Notes

Action items

  • No labels